Skip to content

Better Care for PFAS Patients Act of 2026

In committee: it can still change before the session ends.

US HR 6977 · House Bill · 119th Congress

Stage
In committee
Started in
House
Sponsors
2
Latest action
Jan 8, 2026

What it does

The Better Care for PFAS Patients Act of 2026 would require the Director of the Agency for Toxic Substances and Disease Registry to partner with the National Academies of Sciences, Engineering, and Medicine (or another appropriate entity) to periodically assess the health effects of PFAS measurable in human tissues and formulate clinical recommendations. The bill mandates that an initial assessment and recommendations be completed within two years of the agreement, with updates every five years or more frequently if scientifically warranted, and requires the issuance, posting, and dissemination of up-to-date clinical guidance to state and local health authorities and healthcare…

No official summary is available here. This one was written by AI from the bill’s text.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Jan 8, 2026

  2. Committee (Current step)

    In committee · Jan 8, 2026

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

Better Care for PFAS Patients Act of 2026 | 52